Review



ca19 9 levels  (Monobind)


Bioz Verified Symbol Monobind is a verified supplier
Bioz Manufacturer Symbol Monobind manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Monobind ca19 9 levels
    Ca19 9 Levels, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 47 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19 9 levels/product/Monobind
    Average 94 stars, based on 47 article reviews
    ca19 9 levels - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    94
    Monobind ca19 9 levels
    Ca19 9 Levels, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19 9 levels/product/Monobind
    Average 94 stars, based on 1 article reviews
    ca19 9 levels - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    86
    Tosoh Corporation human serum ca19 9 level
    Human Serum Ca19 9 Level, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human serum ca19 9 level/product/Tosoh Corporation
    Average 86 stars, based on 1 article reviews
    human serum ca19 9 level - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    90
    Tosoh Corporation analysis of serum tfpi2, ca125, ca19-9, and cea levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Analysis Of Serum Tfpi2, Ca125, Ca19 9, And Cea Levels, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/analysis of serum tfpi2, ca125, ca19-9, and cea levels/product/Tosoh Corporation
    Average 90 stars, based on 1 article reviews
    analysis of serum tfpi2, ca125, ca19-9, and cea levels - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Tosoh Corporation ca19-9 level
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Level, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19-9 level/product/Tosoh Corporation
    Average 90 stars, based on 1 article reviews
    ca19-9 level - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Johns Hopkins HealthCare ca19-9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Levels, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19-9 levels/product/Johns Hopkins HealthCare
    Average 90 stars, based on 1 article reviews
    ca19-9 levels - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Wolters Kluwer Health ca19-9 level
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Level, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19-9 level/product/Wolters Kluwer Health
    Average 90 stars, based on 1 article reviews
    ca19-9 level - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher ca19 9 concentration serum levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Concentration Serum Levels, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19 9 concentration serum levels/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    ca19 9 concentration serum levels - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    90
    SATAKE serum ca19-9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Serum Ca19 9 Levels, supplied by SATAKE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serum ca19-9 levels/product/SATAKE
    Average 90 stars, based on 1 article reviews
    serum ca19-9 levels - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Takeda scc, ca125, ca19-9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Scc, Ca125, Ca19 9 Levels, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/scc, ca125, ca19-9 levels/product/Takeda
    Average 90 stars, based on 1 article reviews
    scc, ca125, ca19-9 levels - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    85
    Cusabio ca19 9 levels
    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
    Ca19 9 Levels, supplied by Cusabio, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ca19 9 levels/product/Cusabio
    Average 85 stars, based on 1 article reviews
    ca19 9 levels - by Bioz Stars, 2026-06
    85/100 stars
      Buy from Supplier

    Image Search Results


    Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

    Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

    Techniques:

    Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

    Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

    Techniques:

    Multivariate analysis of prognostic factors for overall survival

    Journal: BMC Cancer

    Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

    doi: 10.1186/s12885-024-12827-0

    Figure Lengend Snippet: Multivariate analysis of prognostic factors for overall survival

    Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

    Techniques: